PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-251

  1. 224 Posts.
    lightbulb Created with Sketch. 24
    Yippie for what I think was a great announcement.
    I see a sea of buying opportunity.
    Obviously not happy with the crash in price, but can't do much about it. Worse for the holders that were trying to make a quick buck, but I'm in it for the long haul. Fingers crossed that in a few years a lot of us will be laughing with the shares purchased at this price.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.